Amedisys Home Health Care Location: 273 Azalea Road, Suite 204, Bldg 2, Mobile, Alabama 36609 Ratings: Phone: (251) 380-0492 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Saad Healthcare Location: 1515 University Blvd, South, Mobile, Alabama 36609 Ratings: Phone: (251) 343-9600 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Infirmary Homecare Location: 1142-a Montlimar Drive, Mobile, Alabama 36609 Ratings: Phone: (251) 450-3300 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Springhill Home Health And Hospice Location: 10 Mobile Street, Mobile, Alabama 36607 Ratings: Phone: (251) 433-8172 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Encompass Health Home Health Location: 6333 Cottage Hill Road, Mobile, Alabama 36609 Ratings: Phone: (251) 341-0707 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Kindred At Home Location: 824 Western America Drive, Mobile, Alabama 36609 Ratings: Phone: (251) 316-0917 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Parallax® Contour® Vertebral Augmentation Device (Contour) specifically for void creation in a vertebral body followed by injection of bone cement. Vertebral body void creation followed by bone cement augmentation is commonly used to treat painful vertebral compression fractures.
In just four months since its launch, DRIVE4COPD has already encouraged more than 100,000 people to be screened to see if they may be at risk for chronic obstructive pulmonary disease. The country's newest health initiative that aims to raise awareness of COPD in the hopes that people will talk to their doctor and get diagnosed instead of suffering in silence. Currently, half of the estimated 24 million Americans who may have COPD remain undiagnosed and untreated, and most are not diagnosed until they have lost half their lung function.
Early-stage colon cancer patients could benefit in the future from specific genetic tests that forecast their prognosis and help them make the right decision regarding chemotherapy.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing four new Research Units. The decision was made by the DFG Senate at its December session in Bonn. The establishment of the Research Units will enable researchers to explore prevailing topical questions and generate new approaches in their respective fields.
› Verified 2 days ago